ADMA 生物製劑公司
US ˙ NasdaqGM ˙ US0008991046

SecurityADMA / ADMA Biologics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership401,682 shares
Latest Disclosed Value $ 7,314,629
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 4.66% increase in ownership of ADMA / ADMA Biologics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 401,682 shares of ADMA Biologics, Inc. (US:ADMA) valued at $7,314,629 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 383,799 shares of ADMA Biologics, Inc.. This represents a change in shares of 4.66% during the quarter. The current value of the position is $3,201,406 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP ADMA Biologics EC US0008991046 401,682 17,883 4.66 7,315 -3.94 0.1643
2025-05-28 2025-03-31 NP ADMA Biologics EC US0008991046 383,799 4,074 1.07 7,615 16.92 0.1827
2025-02-25 2024-12-31 NP ADMA Biologics EC US0008991046 379,725 -60,694 -13.78 6,512 -26.03 0.1422
2024-11-26 2024-09-30 NP ADMA Biologics EC US0008991046 440,419 35,843 8.86 8,804 94.63 0.1665
2024-08-26 2024-06-30 NP ADMA Biologics EC US0008991046 404,576 28,229 7.50 4,523 82.16 0.0921
2024-05-28 2024-03-31 NP ADMA Biologics EC US0008991046 376,347 -9,141 -2.37 2,484 42.54 0.0518
2024-02-26 2023-12-31 NP ADMA Biologics EC US0008991046 385,488 24,139 6.68 1,742 34.73 0.0372
2023-11-28 2023-09-30 NP ADMA Biologics EC US0008991046 361,349 -5,522 -1.51 1,294 -4.43 0.0337
2023-08-25 2023-06-30 NP ADMA Biologics EC US0008991046 366,871 36,196 10.95 1,354 23.67 0.0321
2023-05-26 2023-03-31 NP ADMA Biologics EC US0008991046 330,675 41,328 14.28 1,095 -2.50 0.0291
2023-02-24 2022-12-31 NP ADMA Biologics EC US0008991046 289,347 2,230 0.78 1,123 60.98 0.0309
2022-11-25 2022-09-30 NP ADMA Biologics EC US0008991046 287,117 0 0.00 698 22.71 0.0200
2022-08-25 2022-06-30 NP ADMA Biologics EC US0008991046 287,117 190,565 197.37 568 236.09 0.0157
2021-05-27 2021-03-31 NP ADMA Biologics EC US0008991046 96,552 0 0.00 170 -10.11 0.0039
2021-02-25 2020-12-31 NP ADMA Biologics EC US0008991046 96,552 0 0.00 188 -18.26 0.0048
2020-11-25 2020-09-30 NP ADMA Biologics EC US0008991046 96,552 0 0.00 231 -18.44 0.0074
2020-08-27 2020-06-30 NP ADMA Biologics EC US0008991046 96,552 -15,908 -14.15 283 -12.69 0.0092
2020-06-01 2020-03-31 NP ADMA Biologics EC US0008991046 112,460 35,428 45.99 324 4.87 0.0132
2020-02-27 2019-12-31 NP ADMA Biologics EC 000899104 77,032 1,162 1.53 308 -8.61 0.0093
2019-11-27 2019-09-30 NP ADMA Biologics EC US0008991046 75,870 75,870 338 0.0112
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.